H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on ChromaDex (CDXC) to $11 from $8 and keeps a Buy rating on the shares. The company reported a modest sales beat and “impressive” earnings outperformance with multiple revenue accelerants, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXC: